Rep. Robert Bresnahan, Jr. Buys Waters Co. (NYSE:WAT) Stock

Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently bought shares of Waters Co. (NYSE:WAT). In a filing disclosed on March 27th, the Representative disclosed that they had bought between $1,001 and $15,000 in Waters stock on February 25th. The trade occurred in the Representative’s “JP MORGAN BROKERAGE ACCOUNT” account.

Representative Robert Bresnahan, Jr. also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Intuit (NASDAQ:INTU) on 3/7/2025.
• Sold $1,001 – $15,000 in shares of Tesla (NASDAQ:TSLA) on 3/6/2025.
• Purchased $1,001 – $15,000 in shares of SEA (NYSE:SE) on 3/5/2025.
• Sold $1,001 – $15,000 in shares of Credo Technology Group (NASDAQ:CRDO) on 3/4/2025.
• Purchased $1,001 – $15,000 in shares of Meta Platforms (NASDAQ:META) on 3/4/2025.
• Purchased $1,001 – $15,000 in shares of Twilio (NYSE:TWLO) on 3/4/2025.
• Sold $15,001 – $50,000 in shares of Alibaba Group (NYSE:BABA) on 3/4/2025.
• Purchased $1,001 – $15,000 in shares of Zoom Video Communications (NASDAQ:ZM) on 3/4/2025.
• Purchased $1,001 – $15,000 in shares of Intel (NASDAQ:INTC) on 3/3/2025.
• Purchased $1,001 – $15,000 in shares of Snowflake (NYSE:SNOW) on 3/3/2025.

Waters Trading Down 2.4 %

Shares of WAT stock opened at $361.61 on Friday. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.65 and a current ratio of 0.94. Waters Co. has a 52-week low of $279.24 and a 52-week high of $423.56. The stock has a fifty day simple moving average of $387.41 and a two-hundred day simple moving average of $372.29. The firm has a market capitalization of $21.48 billion, a PE ratio of 33.76, a PEG ratio of 3.79 and a beta of 1.00.

Waters (NYSE:WAT) last released its quarterly earnings data on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%. On average, analysts predict that Waters Co. will post 12.86 EPS for the current fiscal year.

Hedge Funds Weigh In On Waters

Institutional investors have recently added to or reduced their stakes in the company. Aster Capital Management DIFC Ltd acquired a new stake in Waters during the fourth quarter valued at approximately $28,000. Bank of Jackson Hole Trust bought a new position in Waters during the fourth quarter worth $34,000. Fortitude Family Office LLC boosted its holdings in Waters by 235.7% in the fourth quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier’s stock worth $35,000 after purchasing an additional 66 shares during the period. Steward Partners Investment Advisory LLC increased its stake in Waters by 129.3% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 94 shares of the medical instruments supplier’s stock valued at $35,000 after purchasing an additional 53 shares during the last quarter. Finally, Murphy & Mullick Capital Management Corp acquired a new stake in shares of Waters during the fourth quarter worth $42,000. Institutional investors and hedge funds own 94.01% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have weighed in on WAT. Robert W. Baird upgraded Waters from a “neutral” rating to an “outperform” rating and upped their target price for the stock from $396.00 to $407.00 in a report on Wednesday. StockNews.com downgraded Waters from a “buy” rating to a “hold” rating in a research report on Tuesday, February 25th. Barclays raised shares of Waters from an “underweight” rating to an “equal weight” rating and raised their price target for the stock from $360.00 to $415.00 in a research report on Monday, February 10th. Bank of America lowered their target price on Waters from $430.00 to $410.00 and set a “neutral” rating on the stock in a research note on Thursday, February 13th. Finally, Baird R W upgraded shares of Waters from a “hold” rating to a “strong-buy” rating in a research report on Wednesday. Ten investment analysts have rated the stock with a hold rating, six have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $397.40.

About Representative Bresnahan

Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania’s 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania’s 8th Congressional District. He declared candidacy for the 2026 election.

Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.